|Bid||15.00 x 900|
|Ask||15.62 x 1200|
|Day's Range||14.67 - 15.62|
|52 Week Range||11.46 - 18.02|
|Beta (5Y Monthly)||2.21|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 03, 2022|
|Forward Dividend & Yield||0.20 (1.39%)|
|Ex-Dividend Date||Dec 02, 2021|
|1y Target Est||18.00|
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of NOV Inc.Global Credit Research - 21 Jan 2022New York, January 21, 2022 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of NOV Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review discussion held on 19 January 2022 in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. Since 1 January 2019, Moody's practice has been to issue a press release following each periodic review to announce its completion.This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
Investment company Nepsis, Inc. (Current Portfolio) buys Qualcomm Inc, NOV Inc, Cigna Corp, F5 Inc, General Mills Inc, sells Ventas Inc, Fulgent Genetics Inc, American International Group Inc, Freshworks Inc, Freshworks Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Nepsis, Inc..
Investment company Syntax Etf Trust (Current Portfolio) buys Perrigo Co PLC, Unum Group, GameStop Corp, Performance Food Group Co, NOV Inc, sells Ligand Pharmaceuticals Inc, CMC Materials Inc, Cinemark Holdings Inc, Bio-Techne Corp, Treehouse Foods Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Syntax Etf Trust.